Speaker
Bin Pan, Juliet Moritz
When and where
Starts: Thursday, 24 April 2025 - 10:00
Ends: Thursday, 24 April 2025 - 11:00
Location:
Xtalks, Toronto, Canada
Location details: Free Registration on Xtalks.com
Event description
First-in-human (FIH) oncology trials serve as a pivotal transition from preclinical research to patient care, marking the first step in validating the safety and biological activity of a novel therapeutic in humans. These early-phase studies generate essential data on dosing, pharmacokinetics and preliminary efficacy signals, setting the stage for subsequent clinical development.
FIH oncology trials require careful preparation and strategic implementation from study design and investigational new drug (IND) submission to site startup, patient recruitment and cohort management. To ensure success, sponsors must navigate a host of challenges to ensure safety, timeliness and scientific validity.
This webinar will highlight key considerations and best practices for designing and executing FIH oncology trials, offering practical solutions to help sponsors navigate the regulatory, operational and clinical hurdles inherent to these studies. The key topics will include:
- Preparing a robust IND package
- Developing a clear plan for dose escalation
- Streamlining site initiation and patient recruitment
- Managing cohorts and safety review committees
Register for this webinar to explore best practices such as regulatory preparation, site initiation, cohort management and safety monitoring for designing and executing first-in-human oncology trials.
Further details
IMPORTANT: In order to register to this free webinar you must register directly on Xtalks via the following URL: https://xtalks.com/webinars/exploring-the-challenges-of-designing-and-executing-first-in-human-oncology-trials/
Geolocation will be visible after you sign in.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 81
- Comments 0